| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |